Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galina N Nikolenko

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Virology|December 15, 2004
Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transferJean L Mbisa, Galina N Nikolenko, Vinay K Pathak
Journal of Virology|March 12, 2010
A novel molecular mechanism of dual resistance to nucleoside and nonnucleoside reverse transcriptase inhibitorsGalina N Nikolenko, Krista A Delviks-Frankenberry, Vinay K Pathak
Viruses|November 20, 2010
The "Connection" Between HIV Drug Resistance and RNase HKrista A Delviks-Frankenberry, Galina N Nikolenko, Vinay K Pathak
Journal of Virology|July 29, 2004
Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequencyGalina N Nikolenko, Evguenia S Svarovskaia, Krista A Delviks, et al.
Journal of Virology|April 13, 2007
Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistanceKrista A Delviks-Frankenberry, Galina N Nikolenko, Rebekah Barr, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2005
Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excisionGalina N Nikolenko, Sarah Palmer, Frank Maldarelli, et al.
Journal of Virology|June 26, 2009
Subtype-specific differences in the human immunodeficiency virus type 1 reverse transcriptase connection subdomain of CRF01_AE are associated with higher levels of resistance to 3'-azido-3'-deoxythymidineKrista A Delviks-Frankenberry, Galina N Nikolenko, Frank Maldarelli, et al.
Journal of Virology|February 23, 2007
Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysisDavid C Thomas, Yegor A Voronin, Galina N Nikolenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistanceGalina N Nikolenko, Krista A Delviks-Frankenberry, Sarah Palmer, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutationsRenan B Lengruber, Krista A Delviks-Frankenberry, Galina N Nikolenko, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Virology|December 15, 2004
Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transferJean L Mbisa, Galina N Nikolenko, Vinay K Pathak
Journal of Virology|March 12, 2010
A novel molecular mechanism of dual resistance to nucleoside and nonnucleoside reverse transcriptase inhibitorsGalina N Nikolenko, Krista A Delviks-Frankenberry, Vinay K Pathak
Viruses|November 20, 2010
The "Connection" Between HIV Drug Resistance and RNase HKrista A Delviks-Frankenberry, Galina N Nikolenko, Vinay K Pathak
Journal of Virology|July 29, 2004
Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequencyGalina N Nikolenko, Evguenia S Svarovskaia, Krista A Delviks, et al.
Journal of Virology|April 13, 2007
Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistanceKrista A Delviks-Frankenberry, Galina N Nikolenko, Rebekah Barr, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2005
Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excisionGalina N Nikolenko, Sarah Palmer, Frank Maldarelli, et al.
Journal of Virology|June 26, 2009
Subtype-specific differences in the human immunodeficiency virus type 1 reverse transcriptase connection subdomain of CRF01_AE are associated with higher levels of resistance to 3'-azido-3'-deoxythymidineKrista A Delviks-Frankenberry, Galina N Nikolenko, Frank Maldarelli, et al.
Journal of Virology|February 23, 2007
Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysisDavid C Thomas, Yegor A Voronin, Galina N Nikolenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistanceGalina N Nikolenko, Krista A Delviks-Frankenberry, Sarah Palmer, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutationsRenan B Lengruber, Krista A Delviks-Frankenberry, Galina N Nikolenko, et al.
Pageof 2